Cytotoxics Injectables

The pharmaceutical development and production of oncological drugs is one of Aenova's most important service areas. Our highly qualified team of experts has state-of-the-art facilities and barrier technologies for the development of parenteral forms up to OEB category 5.


For your specific requirements simply contact us!

Capacity: 45 million vials
OEB level:
4-5

Product Features
Locations

APIs

  • Anti-Metabolites
  • Taxanes
  • Topoisomerase and mitosis inhibitors
  • Enzyme inhibitors
  • Immunosuppressants
  • Others

Dosage forms

  • Liquid vials

Services

  • Bulk compounding and filling
  • Packaging
  • Serialization and aggregation

Packaging

  • Blister packaging
  • Folding boxes
  • Specific configurations